HF
CANF

HRT Financial’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

HRT Financial’s Portfolio CANF Stock Details CANF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,383
Closed -$60K – 4283
2026
Q1 		$60K Buy
+19,383
New +$80.1K ﹤0.01% 3431
2024
Q3 		– Sell
-540
Closed -$27K – 2478
2024
Q2 		$27K Buy
+540
New +$25.5K ﹤0.01% 1904
2022
Q1 		– Sell
-60
Closed -$15K – 3152
2021
Q4 		$15K Buy
+60
New +$16.5K ﹤0.01% 2983

Other funds holding CANF

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HRT Financial's CANF Position: Q2 2026 in Review

HRT Financial sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q2 2026, closing a stake of 19,383 shares — an estimated $60K sold.

HRT Financial first reported a position in CANF in Q4 2021 and held it in 3 quarters. The position peaked at $60K in Q1 2026. 8 funds tracked by Wall St. Rank hold CANF as of Q2 2026.

  • HRT Financial reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 19,383 Can-Fite BioPharma American Depositary Shares shares in Q2 2026, an estimated $60K.
  • HRT Financial first reported a position in Can-Fite BioPharma American Depositary Shares in Q4 2021 and held it in 3 quarters.
  • HRT Financial's Can-Fite BioPharma American Depositary Shares position peaked at $60K in Q1 2026.
  • 8 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.